|
CISD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.177200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.454400E-01 |
| Normal-vs-Stage2 |
1.400430E-01 |
| Normal-vs-Stage3 |
2.813000E-01 |
| Normal-vs-Stage4 |
4.480700E-03 |
| Stage1-vs-Stage2 |
6.919800E-02 |
| Stage1-vs-Stage3 |
1.345210E-01 |
| Stage1-vs-Stage4 |
4.997900E-02 |
| Stage2-vs-Stage3 |
7.307000E-01 |
| Stage2-vs-Stage4 |
6.175600E-01 |
| Stage3-vs-Stage4 |
3.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.763000E-01 |
| Normal-vs-AfricanAmerican |
8.094800E-01 |
| Normal-vs-Asian |
7.266800E-01 |
| Caucasian-vs-AfricanAmerican |
4.324000E-01 |
| Caucasian-vs-Asian |
7.915600E-01 |
| AfricanAmerican-vs-Asian |
6.956800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.076600E-01 |
| Normal-vs-Female |
1.272180E-01 |
| Male-vs-Female |
5.465600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.489800E-01 |
| Normal-vs-Extreme_Weight |
8.582600E-01 |
| Normal-vs-Obese |
8.859400E-01 |
| Normal-vs-Extreme_Obese |
9.699000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.148600E-01 |
| Normal_Weight-vs-Obese |
2.095400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.695400E-01 |
| Extreme_Weight-vs-Obese |
9.723000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.535400E-01 |
| Obese-vs-Extreme_Obese |
9.616200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.492600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.568800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.752600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.931400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.337000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.339200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.298400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.783600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.061000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.071400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.892230E-01 |
| Normal-VS-Type2 PRCC |
8.996700E-03 |
| Normal-VS-KIRP CIMP |
9.625800E-01 |
| Normal-VS-Unclassified PRCC |
9.467400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.965600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.620400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.129800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.821000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.671630E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.832400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.460200E-01 |
| Normal-vs-N1 |
1.363850E-01 |
| Normal-vs-N2 |
5.054200E-02 |
| N0-vs-N1 |
7.775600E-01 |
| N0-vs-N2 |
2.755800E-01 |
| N1-vs-N2 |
4.917200E-01 |
|
|
